Centenial surgical suture Ltd. has announced the approval of its quarterly financial results through a regulatory filing with BSE Limited. The company's Board of Directors convened on February 12, 2026, to review and approve key financial disclosures for the reporting period.

Board Meeting Details

The board meeting was conducted on Thursday, February 12, 2026, with specific timing and procedural compliance maintained throughout the session.

Financial Results Approval

The primary agenda item addressed during the board meeting was the approval of standalone unaudited financial results. The results cover comprehensive financial performance for both quarterly and nine-month periods.

Regulatory Compliance

The announcement was made in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure follows Regulation 30 read with Schedule III(A)(IV) of the SEBI LODR framework, ensuring transparency and timely communication to stakeholders.

Corporate Governance

The filing was signed by Mahima Bathwal, Company Secretary & Compliance Officer, who holds membership number ACS A35069. The digital signature was applied on February 12, 2026, at 19:09:53 +05'30', confirming the authenticity and timing of the regulatory submission to BSE Limited.

Centenial Surgical Suture Ltd has announced a significant change to its Audit Committee, reinforcing its commitment to robust corporate governance. The company has appointed Neel Vora, an Independent Non-Executive Director, as a new member of the Audit Committee, effective October 10, 2025.

Key Highlights

• Neel Vora (DIN: 07699873) joins the Audit Committee as an Independent Non-Executive Director
• Appointment made through a Circular Resolution passed by the Board of Directors
• Effective date of appointment: October 10, 2025

Reconstituted Audit Committee

The newly reconstituted Audit Committee now comprises four members, balancing independent oversight with management representation:

This restructuring of the Audit Committee aligns with Centenial Surgical Suture Ltd's ongoing efforts to maintain high standards of financial oversight and transparency. The inclusion of Neel Vora, another independent director, further strengthens the committee's independence and diversity of perspective.

The company has duly informed the BSE Limited about this change, in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Centenial Surgical Suture Ltd, a company engaged in the manufacturing of surgical sutures, continues to demonstrate its commitment to good corporate governance practices through this strategic appointment to its Audit Committee.